Literature DB >> 22102440

Prognosis and staging of non-alcoholic fatty liver disease.

Peter Jepsen, Henning Grønbæk.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22102440     DOI： 10.1136/bmj.d7302

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.

Authors:  N Husain; P Blais; J Kramer; M Kowalkowski; P Richardson; H B El-Serag; F Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2014-08-26       Impact factor: 8.171

2.  Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.

Authors:  Jung Il Lee; Jung-Hwan Yu; Sung Gwe Anh; Hyun Woong Lee; Joon Jeong; Kwan Sik Lee
Journal:  Oncologist       Date:  2019-01-24

3.  Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.

Authors:  Paola Stiuso; Ilaria Scognamiglio; Marianna Murolo; Pasquale Ferranti; Carmela De Simone; Maria Rosaria Rizzo; Concetta Tuccillo; Michele Caraglia; Carmelina Loguercio; Alessandro Federico
Journal:  Oxid Med Cell Longev       Date:  2014-06-02       Impact factor: 6.543
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.